Gillian M Keating

Summary

Publications

  1. ncbi request reprint Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:2077-91. 2013
  2. ncbi request reprint Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 28:1083-97. 2014
  3. ncbi request reprint Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:53-60. 2014
  4. ncbi request reprint Pramipexole extended-release: a review of its use in patients with Parkinson's disease
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2175-90. 2014
  5. ncbi request reprint Avanafil: a review of its use in patients with erectile dysfunction
    Mark Sanford
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs Aging 30:853-62. 2013
  6. ncbi request reprint Ivacaftor: a review of its use in patients with cystic fibrosis
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1595-604. 2013
  7. ncbi request reprint Dolutegravir: a review of its use in the management of HIV-1 infection in adolescents and adults
    Paul L McCormack
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1241-52. 2014
  8. ncbi request reprint Albumin-bound paclitaxel: a review of its use for the first-line combination treatment of metastatic pancreatic cancer
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1757-68. 2014
  9. ncbi request reprint Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:195-206. 2014
  10. ncbi request reprint Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:895-904. 2014

Collaborators

Detail Information

Publications240 found, 100 shown here

  1. ncbi request reprint Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:2077-91. 2013
    ..Although the final overall survival data in men with metastatic CRPC who have not previously received chemotherapy are awaited, current evidence indicates that abiraterone acetate is a useful option for the treatment of metastatic CRPC. ..
  2. ncbi request reprint Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 28:1083-97. 2014
    ..Therefore, oral rasagiline is a valuable therapeutic option for use in all stages of Parkinson's disease...
  3. ncbi request reprint Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:53-60. 2014
    ..Linaclotide was generally well tolerated; the most common adverse event was diarrhoea. Thus, linaclotide is a novel and effective single agent for the treatment of IBS-C in adults...
  4. ncbi request reprint Pramipexole extended-release: a review of its use in patients with Parkinson's disease
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2175-90. 2014
    ....
  5. ncbi request reprint Avanafil: a review of its use in patients with erectile dysfunction
    Mark Sanford
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs Aging 30:853-62. 2013
    ..During extended treatment with avanafil for >52 weeks, 2.8 % of patients discontinued treatment because of adverse reactions and there were no drug-related serious adverse events...
  6. ncbi request reprint Ivacaftor: a review of its use in patients with cystic fibrosis
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1595-604. 2013
    ..Thus, ivacaftor expands the current treatment options for patients with cystic fibrosis who have the G551D mutation. Its potential for use in patients with other CFTR mutations is also of interest. ..
  7. ncbi request reprint Dolutegravir: a review of its use in the management of HIV-1 infection in adolescents and adults
    Paul L McCormack
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1241-52. 2014
    ..Therefore, dolutegravir is an important new addition to the expanding list of antiretroviral drugs for treating HIV-1 infection in adults and adolescents. ..
  8. ncbi request reprint Albumin-bound paclitaxel: a review of its use for the first-line combination treatment of metastatic pancreatic cancer
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1757-68. 2014
    ..Current evidence indicates that nab-paclitaxel plus gemcitabine is a valuable option for the treatment of metastatic pancreatic cancer. ..
  9. ncbi request reprint Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:195-206. 2014
    ..Thus, cobicistat is an emerging alternative to ritonavir for the pharmacokinetic enhancement of PIs in adults with HIV-1 infection...
  10. ncbi request reprint Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:895-904. 2014
    ..In conclusion, defibrotide is the only agent approved (in the EU) for use in severe hepatic VOD following HSCT and represents a useful advance in the treatment of this condition...
  11. ncbi request reprint Epoprostenol (veletri(®), caripul (®)): a review of its use in patients with pulmonary arterial hypertension
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 14:463-70. 2014
    ..Therefore, epoprostenol AS is a valuable therapeutic option that has the potential to overcome some of the limitations of long-term intravenous epoprostenol therapy in patients with PAH. ..
  12. ncbi request reprint Fingolimod: a review of its use in relapsing-remitting multiple sclerosis
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1411-33. 2014
    ..It has an acceptable tolerability profile and provides a useful alternative treatment in patients with RRMS who have responded poorly to other DMAs...
  13. ncbi request reprint Bosutinib: a review of its use in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    BioDrugs 28:107-20. 2014
    ..Therefore, bosutinib is a useful TKI option for patients with Ph+ CML in second-line or greater settings...
  14. ncbi request reprint Tafamidis: a review of its use in familial amyloid polyneuropathy
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1371-8. 2014
    ..No new safety signals have emerged during long-term extension studies and post-marketing experience...
  15. ncbi request reprint Dapagliflozin: a review of its use in patients with type 2 diabetes
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2191-209. 2014
    ....
  16. ncbi request reprint Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:2161-74. 2014
    ..Thus, liraglutide continues to be a useful option for the management of type 2 diabetes. This article reviews the therapeutic use of liraglutide in adult patients with type 2 diabetes and summarizes its pharmacological properties...
  17. ncbi request reprint Sitagliptin: a review of its use in patients with type 2 diabetes mellitus
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:223-42. 2014
    ..A similar review is planned in the USA and postmarketing surveillance will continue. Thus, oral sitagliptin is an effective and generally well tolerated treatment option for the management of patients with type 2 diabetes. ..
  18. ncbi request reprint Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis
    Sohita Dhillon
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    BioDrugs 28:75-106. 2014
    ....
  19. ncbi request reprint Macitentan: a review of its use in patients with pulmonary arterial hypertension
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1495-507. 2014
    ....
  20. ncbi request reprint Trastuzumab emtansine: a review of its use in patients with HER2-positive advanced breast cancer previously treated with trastuzumab-based therapy
    Sohita Dhillon
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:675-86. 2014
    ....
  21. ncbi request reprint Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia
    Matt Shirley
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1097-110. 2014
    ..It may be of particular use for patients stable on oral aripiprazole who would prefer, or are likely to benefit from, a long-acting formulation. ..
  22. ncbi request reprint Nivolumab: a review of its use in patients with malignant melanoma
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1233-9. 2014
    ..Thus, nivolumab is an emerging, promising option for the treatment of malignant melanoma. ..
  23. ncbi request reprint Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders
    Mark Sanford
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 28:411-20. 2014
    ..Most patients preferred IGHy over intravenous administration. IGHy offers a new method for subcutaneous delivery of human immunoglobulin replacement therapy in patients with PIDs...
  24. ncbi request reprint Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer
    Lily P H Yang
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
    Mol Diagn Ther 18:105-16. 2014
    ..Although its impact on disease progression and survival rates is not yet known, HAL-BLC is a valuable addition to WLC for the diagnosis of bladder cancer in patients who are suitable candidates for its use. ..
  25. ncbi request reprint Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1951-66. 2013
    ..g. diarrhoea, nausea) reported most commonly. In conclusion, single-dose fosfomycin trometamol is an important option for the first-line empirical treatment of uncomplicated lower UTIs. ..
  26. ncbi request reprint Denosumab: a review of its use in postmenopausal women with osteoporosis
    Lesley J Scott
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs Aging 31:555-76. 2014
    ....
  27. ncbi request reprint Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis
    Sohita Dhillon
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:999-1016. 2014
    ....
  28. ncbi request reprint QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease
    James E Frampton
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:465-88. 2014
    ..Therefore, it is a valuable option in the treatment of COPD. ..
  29. ncbi request reprint Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism
    Celeste B Burness
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:243-62. 2014
    ..In conclusion, rivaroxaban is a reasonable alternative to standard therapy for the treatment of DVT and PE, and as extended thromboprophylaxis...
  30. ncbi request reprint Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis
    Celeste B Burness
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    CNS Drugs 28:373-87. 2014
    ....
  31. ncbi request reprint Rivaroxaban: a review of its use in acute coronary syndromes
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:451-64. 2014
    ..5 mg twice daily co-administered with aspirin alone or aspirin plus either clopidogrel or ticlopidine in patients with a recent ACS. ..
  32. ncbi request reprint Zonisamide: a review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged ≥6 years
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 16:235-46. 2014
    ..Thus, oral zonisamide as an adjunctive therapy to other AEDs provides a useful option in the treatment of pediatric patients aged ≥6 years with partial seizures...
  33. ncbi request reprint Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:563-78. 2014
    ..Thus, add-on THC/CBD is a useful symptomatic treatment option for its approved indication...
  34. ncbi request reprint Darunavir: a review of its use in the management of HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901 Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:99-125. 2014
    ..Thus, boosted darunavir is a useful option for the ART regimens of adult and paediatric patients with HIV-1 infection. ..
  35. ncbi request reprint Miglustat: a review of its use in Niemann-Pick disease type C
    Katherine A Lyseng-Williamson
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:61-74. 2014
    ....
  36. ncbi request reprint Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:63-80. 2014
    ..In conclusion, sodium oxybate is a useful option for the treatment of alcohol withdrawal syndrome and for the maintenance of abstinence in alcohol dependence. ..
  37. ncbi request reprint Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension
    Mark Sanford
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Clin Drug Investig 34:521-8. 2014
    ..PF latanoprost offers a useful alternative to the available preserved prostaglandin analogues for the treatment of POAG/ocular hypertension...
  38. ncbi request reprint Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:325-51. 2014
    ..Thus, adjunctive exenatide twice daily is a valuable option in the treatment of type 2 diabetes inadequately controlled with OADs and/or basal insulin. ..
  39. ncbi request reprint Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis
    James E Frampton
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 15:515-31. 2013
    ..Clinical laboratory abnormalities included neutropenia and elevated aminotransferase levels. The tolerability profile of tocilizumab in CHERISH was generally consistent with that of the drug in TENDER. ..
  40. ncbi request reprint Etanercept: a review of its use in autoimmune inflammatory diseases
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1379-410. 2014
    ..This article reviews the extensive clinical experience with etanercept in these patient populations...
  41. ncbi request reprint Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1785-800. 2014
    ....
  42. ncbi request reprint Empagliflozin: a review of its use in patients with type 2 diabetes mellitus
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1769-84. 2014
    ..This article reviews the pharmacological properties and clinical use of empagliflozin in patients with type 2 diabetes. ..
  43. ncbi request reprint Linagliptin: an update of its use in patients with type 2 diabetes mellitus
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1927-46. 2014
    ..Meanwhile, the low risk of hypoglycaemia and the nonrenal route of elimination may provide important advantages for some patient groups, including elderly or renally impaired patients...
  44. ncbi request reprint Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1801-16. 2014
    ..In conclusion, tiotropium Respimat(®) Soft Mist™ Inhaler is a useful option for the treatment of patients with COPD. ..
  45. ncbi request reprint Bevacizumab: a review of its use in advanced cancer
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1891-925. 2014
    ..In conclusion, bevacizumab remains an important option for use in patients with advanced cancer...
  46. ncbi request reprint Eltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis C
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1961-71. 2014
    ..Eltrombopag provides a new treatment option for thrombocytopenia in patients with chronic HCV infection to allow for optimal antiviral therapy...
  47. ncbi request reprint Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:2065-78. 2014
    ..Riociguat is a promising addition to the treatment options for patients with CTEPH or PAH. ..
  48. ncbi request reprint Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1947-60. 2014
    ..In conclusion, intravenous clevidipine is a valuable agent for the management of BP in perioperative and intensive care settings...
  49. ncbi request reprint Umeclidinium/Vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:61-74. 2015
    ..Thus, inhaled umeclidinium/vilanterol extends the treatment options currently available for the maintenance treatment of adults with COPD and has the convenience of once-daily administration. ..
  50. ncbi request reprint Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:75-82. 2015
    ..While more data are needed to confirm the efficacy of alectinib and to evaluate its activity in crizotinib-resistant disease, the drug provides a very promising option for the treatment of ALK-rearranged advanced NSCLC. ..
  51. ncbi request reprint Ferric carboxymaltose: a review of its use in iron deficiency
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:101-27. 2015
    ..In conclusion, ferric carboxymaltose is an important option for the treatment of iron deficiency. ..
  52. ncbi request reprint Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 14:393-400. 2014
    ....
  53. ncbi request reprint Omalizumab: a review of its use in patients with chronic spontaneous urticaria
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1693-9. 2014
    ..Thus, omalizumab is an effective and well-tolerated add-on therapy in patients with chronic spontaneous urticaria who are symptomatic despite background therapy with H1 antihistamines. ..
  54. ncbi request reprint Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome)
    Katherine A Lyseng-Williamson
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 28:465-75. 2014
    ..In the absence of a cure, GALNS enzyme replacement therapy with elosulfase alfa is an important achievement in the treatment of MPS IVA. ..
  55. ncbi request reprint Cabozantinib: a review of its use in patients with medullary thyroid cancer
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1435-44. 2014
    ..Although final overall survival data are awaited, current evidence suggests cabozantinib to be a valuable treatment option for adults with progressive, unresectable locally advanced or metastatic MTC...
  56. ncbi request reprint OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury
    Mark Sanford
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1659-72. 2014
    ..Intradetrusor onabotulinumtoxinA represents a clinically important advance in the therapy of UI in patients with MS or SCI who have not responded to antimuscarinics or who are unable to tolerate antimuscarinics. ..
  57. ncbi request reprint 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 15:403-23. 2013
    ....
  58. ncbi request reprint Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1523-42. 2014
    ..Therefore, ceftobiprole medocaril monotherapy offers a simplified option for the initial empirical treatment of patients with HAP (excluding VAP) and in those with CAP requiring hospitalization. ..
  59. ncbi request reprint Vortioxetine: a review of its use in major depressive disorder
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 28:855-74. 2014
    ..Vortioxetine extends the available treatment options for patients with MDD, and further investigation into its comparative efficacy versus other antidepressants will allow for more accurate placement among these treatment options. ..
  60. ncbi request reprint Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1617-25. 2013
    ..Current evidence suggests that ocriplasmin is a useful treatment option for patients with symptomatic vitreomacular adhesion. ..
  61. ncbi request reprint 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Paediatr Drugs 16:425-44. 2014
    ..PHiD-CV has a safety and reactogenicity profile similar to that of other pneumococcal conjugate vaccines. ..
  62. ncbi request reprint Fidaxomicin: a review of its use in patients with Clostridium difficile infection
    Lesley J Scott
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1733-47. 2013
    ..Albeit further clinical experience is required to fully define the position of fidaxomicin, it is a valuable emerging option for the treatment of first episode and recurrent episodes of C. difficile-associated diarrhoea...
  63. ncbi request reprint Levomilnacipran extended-release: a review of its use in adult patients with major depressive disorder
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 28:1071-82. 2014
    ..This article summarizes the clinical use of oral levomilnacipran ER in adults with MDD, and briefly reviews the pharmacological properties of levomilnacipran...
  64. ncbi request reprint Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a review of its use in HIV infection
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2079-95. 2014
    ....
  65. ncbi request reprint Telavancin: a review of its use in patients with nosocomial pneumonia
    Lesley J Scott
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1829-39. 2013
    ..Telavancin offers an alternative treatment option in patients with nosocomial pneumonia caused by Gram-positive S. aureus, including those caused by MRSA and S. aureus isolates with reduced susceptibility to vancomycin...
  66. ncbi request reprint Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:207-21. 2014
    ..In conclusion, afatinib is a valuable new option for use in treatment-naïve or EGFR TKI-naïve patients with advanced lung adenocarcinoma and activating EGFR mutations. ..
  67. ncbi request reprint Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis
    Paul L McCormack
    Adis, 41 Centorian Drive, Private Bag 65901 Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1463-81. 2013
    ..As long as the risk of PML is managed effectively, natalizumab is a valuable therapeutic option for adults with highly active relapsing forms of multiple sclerosis...
  68. ncbi request reprint Prucalopride: a review of its use in the management of chronic constipation
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1935-50. 2013
    ..In conclusion, prucalopride is an important option for use in patients with chronic constipation who have not experienced adequate relief with laxatives. ..
  69. ncbi request reprint Teriflunomide: a review of its use in relapsing multiple sclerosis
    Karly P Garnock-Jones
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    CNS Drugs 27:1103-23. 2013
    ..Oral teriflunomide is a valuable addition to available treatment options for patients with relapsing multiple sclerosis, in particular those patients who prefer an oral drug...
  70. ncbi request reprint Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients
    Yahiya Y Syed
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    CNS Drugs 27:851-61. 2013
    ..Thus, XR-NTX is a useful treatment option for the prevention of relapse to opioid dependence, following opioid detoxification. ..
  71. ncbi request reprint Regorafenib: a review of its use in previously treated patients with progressive metastatic colorectal cancer
    Natalie J Carter
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs Aging 31:67-78. 2014
    ..The introduction of regorafenib expands the currently limited range of effective treatment options in patients with previously treated, progressive mCRC...
  72. ncbi request reprint Extended-release tacrolimus: a review of its use in de novo kidney transplantation
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2053-64. 2014
    ..Therefore, tacrolimus ER retains the immunosuppressive activity of the original formulation in the prophylaxis of transplant rejection in adult de novo kidney transplant recipients and offers the benefits of once-daily administration. ..
  73. ncbi request reprint Sofosbuvir: a review of its use in patients with chronic hepatitis C
    Gillian M Keating
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1127-46. 2014
    ..In conclusion, sofosbuvir represents an important advance in the treatment of chronic hepatitis C. ..
  74. ncbi request reprint Lanreotide autogel(®): a review of its use in the treatment of patients with acromegaly
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 74:1673-91. 2014
    ..Thus, lanreotide ATG continues to be a valuable option in the treatment of acromegaly, with potential advantages being ease of administration and longer dosing intervals in patients who have an adequate response to initial therapy. ..
  75. ncbi request reprint Icosapent ethyl: a review of its use in severe hypertriglyceridemia
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 14:471-8. 2014
    ..Therefore, icosapent ethyl is an effective and well-tolerated agent for the treatment of severe hypertriglyceridemia in adults. ..
  76. ncbi request reprint Ustekinumab: a review of its use in psoriatic arthritis
    Kate McKeage
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1029-39. 2014
    ....
  77. ncbi request reprint Vildagliptin: a review of its use in type 2 diabetes mellitus
    Gillian M Keating
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:587-610. 2014
    ..Thus, oral vildagliptin is a useful option as monotherapy or as add-on therapy for patients with type 2 diabetes...
  78. ncbi request reprint Pregabalin: a review of its use in adults with generalized anxiety disorder
    James E Frampton
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 28:835-54. 2014
    ....
  79. ncbi request reprint Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1509-22. 2014
    ....
  80. ncbi request reprint Delamanid: a review of its use in patients with multidrug-resistant tuberculosis
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:91-100. 2015
    ..In conclusion, delamanid is a useful addition to the treatment options currently available for patients with MDR-TB. ..
  81. ncbi request reprint Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures
    Gillian M Keating
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 28:583-600. 2014
    ..In conclusion, eslicarbazepine acetate is a useful option for the adjunctive treatment of patients with refractory partial-onset seizures...
  82. ncbi request reprint Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:2153-60. 2014
    ..This article reviews the pharmacology and therapeutic efficacy of rifaximin 550 mg twice daily in reducing the recurrence of overt HE episodes in adults with liver disease...
  83. ncbi request reprint Diclofenac potassium powder for oral solution: a review of its use in patients with acute migraine
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 28:761-8. 2014
    ..The oral powder-for-solution formulation of diclofenac potassium is a useful option in the acute treatment of migraine with or without aura. ..
  84. ncbi request reprint Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts
    Paul L McCormack
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1253-83. 2014
    ..Therefore, quadrivalent HPV vaccine offers an effective means to substantially reduce the burden of HPV-related anogenital disease in females and males, particularly cervical cancer and genital warts. ..
  85. ncbi request reprint Ranibizumab: a review of its use in myopic choroidal neovascularization
    Emma D Deeks
    Adis, Level 1, The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 28:403-10. 2014
    ..Ranibizumab was generally well tolerated in RADIANCE, with few patients experiencing serious ocular or non-ocular adverse events...
  86. ncbi request reprint Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia
    James E Frampton
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs Aging 31:639-49. 2014
    ....
  87. ncbi request reprint Pazopanib: a review of its use in the management of advanced renal cell carcinoma
    Paul L McCormack
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627 Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 74:1111-25. 2014
    ..Therefore, pazopanib was noninferior to sunitinib with respect to efficacy in the treatment of advanced renal cell carcinoma, but had a differentiated tolerability profile, which affected HR-QOL and patient preference...
  88. ncbi request reprint Canagliflozin: a review of its use in patients with type 2 diabetes mellitus
    Greg L Plosker
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:807-24. 2014
    ....
  89. ncbi request reprint Ponatinib: a review of its use in adults with chronic myeloid leukaemia or Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Sheridan M Hoy
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:793-806. 2014
    ....
  90. ncbi request reprint A review of CT-P13: an infliximab biosimilar
    Kate McKeage
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    BioDrugs 28:313-21. 2014
    ..In conclusion, CT-P13 is an infliximab biosimilar that provides a useful alternative to reference infliximab in patients requiring infliximab therapy. ..
  91. ncbi request reprint Elvitegravir: a review of its use in adults with HIV-1 infection
    Emma D Deeks
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:687-97. 2014
    ..Thus, single-agent elvitegravir extends the treatment options available for use in the ritonavir-boosted PI-based ART regimens of adults infected with HIV-1 and has the convenience of once-daily administration. ..
  92. ncbi request reprint Degarelix: a review of its use in patients with prostate cancer
    Natalie J Carter
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:699-712. 2014
    ..g. hot flushes, weight increase) were the most common treatment-emergent adverse events. Thus, degarelix is a useful option for the treatment of prostate cancer in patients for whom endocrine treatment is indicated. ..
  93. ncbi request reprint Pomalidomide: a review of its use in patients with recurrent multiple myeloma
    Lesley J Scott
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:549-62. 2014
    ..Thus, combination therapy with pomalidomide plus low-dose dexamethasone is an important emerging treatment option for use as salvage therapy in patients with relapsed and refractory multiple myeloma...
  94. ncbi request reprint Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer
    Mark Sanford
    Adis, Springer Healthcare, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Target Oncol 9:85-94. 2014
    ..On the evidence, subcutaneous trastuzumab is an effective and generally well-tolerated treatment option that is preferred by patients over intravenous administration. ..
  95. ncbi request reprint Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases
    Matt Shirley
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:579-86. 2014
    ..Thus, radium-223 is a valuable addition to the treatment options for this poor-prognosis population...
  96. ncbi request reprint Alemtuzumab: a review of its use in patients with relapsing multiple sclerosis
    Karly P Garnock-Jones
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:489-504. 2014
    ..More investigation is required before final conclusions can be drawn on the correct placement of alemtuzumab in multiple sclerosis treatment; however, it is of a certainty a welcome addition to the treatment options for these patients. ..
  97. ncbi request reprint Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation
    Celeste B Burness
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
    Drugs 74:353-75. 2014
    ..Although more comparative data are needed, oxycodone/naloxone PR is an effective option for use in patients with severe chronic pain, particularly among those with opioid-induced constipation. ..
  98. ncbi request reprint Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder
    Kate McKeage
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    CNS Drugs 28:171-83. 2014
    ....
  99. ncbi request reprint Raltegravir: a review of its use in the management of HIV-1 infection in children and adolescents
    Caroline M Perry
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Paediatr Drugs 16:91-100. 2014
    ....
  100. ncbi request reprint Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults
    Caroline M Perry
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 74:75-97. 2014
    ..It offers advantages over more complex multiple-tablet regimens that may impair treatment adherence, which is fundamental to the successful management of HIV-1 infection...
  101. ncbi request reprint Tobramycin inhalation powder: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Kate McKeage
    Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand
    Drugs 73:1815-27. 2013
    ..aeruginosa infection. Compared with nebulized TIS, TIP has a faster delivery and is more portable and convenient...